Healthcare
Live Price
Offline$16.54
-0.06% today
1Y Change
+11.08%
Window
Jun 23, 2025 → Jun 5, 2026
Coverage: 240 bars · Jun 23, 2025 → Jun 5, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Select Medical Holdings Corporation (SEM) is a Healthcare stock with a market cap of $2.04B and listed on NYSE. The stock last traded around $16.54 and up 11.1% across the available one-year price window (Jun 23, 2025 → Jun 5, 2026). Baseline metrics include revenue growth of +5.1%, EPS growth of -28.9%, a dividend yield of 1.5%. What stands out right now is revenue +5.1%, EPS -28.9%, free cash flow -29.1% with operating margin 5.8% and ROIC 4.8%. The dividend is present but secondary, with a yield around 1.5%. Valuation is more restrained than many high-expectation growth names at P/E 15.2 and price/sales 0.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SEM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SEM
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SEM Max Drawdown
-22.92%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SEM and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$6.2B
-2.0% YoY
FY Net Income
$402.2M
+153.0% YoY
Free Cash Flow
$220.7M
+133.7% YoY
Revenue Growth
+5.1%
EPS Growth
-28.9%
Gross Margin
10.6%
Net Margin
2.4%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.5B | 5.2B | 6.7B | 6.3B | 6.2B |
| Gross Profit | 629M | 634M | 932M | 733M | 919M |
| Operating Income | 335M | 268M | 555M | 403M | 714M |
| EBITDA | 531M | 507M | 790M | 636M | 968M |
| Net Income | 146M | 214M | 243M | 159M | 402M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 27M | 60M | 53M | 98M | 74M |
| Total Assets | 5.9B | 5.6B | 7.7B | 7.7B | 7.4B |
| Total Liabilities | 3.8B | 3.6B | 6.1B | 6.3B | 6.0B |
| Shareholder Equity | 1.7B | 1.7B | 1.3B | 1.1B | 1.1B |
| Total Debt | 3.7B | 2.7B | 4.5B | 5.2B | 4.8B |
| Net Debt | 3.7B | 2.6B | 4.5B | 5.1B | 4.7B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
401M
+40.9% YoY
Capital Expenditures
181M
+5.2% YoY
Free Cash Flow
221M
+133.7% YoY
Key ratios
Gross Margin
10.6%
Operating Margin
5.8%
Net Margin
2.4%
ROE
7.8%
Debt / Equity
0.65x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.